Skip to Main Content
header search
Search
Skip Nav Destination
Issue Cover
Current Issue
Volume 9,
Issue 1
Summer 2022
View This Issue

ISSN: 2331-5180

Frequency: Quarterly

About IJPT

Launched in 2014 as the official journal of the Particle Therapy Co-Operative Group, it is the mission of IJPT to provide a preferred venue for disseminating the most up-to-date information on the clinical, physical, and biological research in proton, light-ion, and heavy charged-particle therapy. Since its founding, IJPT has received articles by nearly 300 prominent radiation oncologists, physicists, and dosimetrists from 200 institutions around the world.

The Summer Issue

Our 2022 International Journal of Particle Therapy Summer Issue offers articles on proton therapy for extremity soft tissue sarcoma, healthcare resource utilization for esophageal cancer, boron neutron capture therapy, late toxicities between IMPT and IMRT for prostate cancer, and more. Read the issue online now.

Dr. Adam Holtzman Appointed IJPT Deputy Operations Editor

Adam L. Holtzman, MD, Assistant Professor in the Department of Radiation Oncology at the University of Florida, Jacksonville, was appointed Deputy Operations Editor for the International Journal of Particle Therapy on March 1, 2022 - read more.

The IJPT 2021 Special Issue 

With 33 articles by renowned international particle therapy authors knowledgeable in head and neck cancer management, our Special Issue is the most definitive guide to a new standard of care. Read the issue.

Set an Email Alert

You can set an email alert using the upper righthand corner widget here.

You can check your alerts here.

Features & Information

Online First

Access IJPT final revision articles prior to their inclusion in our upcoming journal issues.

test

Author Information

Find an overview of IJPT policies, manuscript requirements, and submission process here.

Research Spotlight

Trends in proton and carbon ion therapy to assist clinical choices and research pursuits.

  • ISSN 2331-5180
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept